| Revista: | Brazilian journal of pharmaceutical sciences |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000359871 |
| ISSN: | 1984-8250 |
| Autores: | Zubioli, Arnaldo1 Silva, Maria Angelica Rafaini Covas Pereira da1 Tasca, Raquel Soares2 Curi, Rui3 Bazotte, Roberto Barbosa1 |
| Instituciones: | 1Universidade Estadual de Maringa, Departamento de Farmacologia e Terapeutica, Maringa, Parana. Brasil 2Universidade Estadual de Maringa, Departamento de Farmacia, Maringa, Parana. Brasil 3Universidade de Sao Paulo, Instituto de Ciencias Biomedicas, Sao Paulo. Brasil |
| Año: | 2013 |
| Periodo: | Ene-Mar |
| Volumen: | 49 |
| Número: | 1 |
| Paginación: | 85-94 |
| País: | Brasil |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Experimental |
| Resumen en inglés | This study develops and evaluates a pharmaceutical consultation program (PCP) to improve treatment for Type 2 diabetes patients (T2DP) and reduce risk factors for diabetic complications with possible application in other chronic diseases. We recruited T2DP receiving conventional medical treatment but with fasting glycemia >140mg/dl and/or glycated hemoglobin >7%. The PCP includes strategies obtained from Dader's method, the PWDT (Pharmacist's Workup of Drug Therapy method) model of pharmaceutical care, the SOAP (Subjective data, Objective data, Assessment, and Plan of care) method, and concepts based on a nursing care model. The PCP evaluated lifestyle, pharmacotherapy and monitoring it using laboratory tests, vital signs, and anthropometry. These procedures were repeated every 4 months for 1 year. Data obtained in each consultation were used to provide patient education focusing on healthy lifestyles and medications. Fifty patients completed the PCP. There were reductions in glycemia (P<0.0001), glycated hemoglobin (P=0.0022), cholesterolemia (P=0.0072), triacylglycerolemia (P=0.0204) and blood pressure (P<0.0001). Increased concordance with drug treatment and correction of drug-related problems contributed to improved treatment. We can therefore conclude that our PCP was suitable for improving health outcomes in T2DP by reducing risk factors for diabetic complications |
| Resumen en portugués | Neste estudo, desenvolvemos e avaliamos um programa de consulta farmacêutica (PCF) visando melhorar o tratamento de pacientes diabéticos tipo 2 (PDT2) e reduzir os fatores de risco de complicações diabéticas com possibilidade de aplicação em outras doenças crônicas. Para alcançar este propósito, PDT2 recebendo tratamento médico convencional, apresentando glicemia de jejum > 140 mg/dl e/ou hemoglobina glicada >7% foram selecionados. O PCF inclui estratégias obtidas a partir do método de Dader, do modelo de cuidados farmacêutico .. |
| Disciplinas: | Química, Medicina |
| Palabras clave: | Química farmacéutica, Metabolismo y nutrición, Terapéutica y rehabilitación, Atención farmacéutica, Diabetes mellitus tipo 2, Tratamiento, Consulta médica, Hemoglobina glicosilada, Diabetes |
| Keyword: | Chemistry, Medicine, Medicinal chemistry, Metabolism and nutrition, Therapeutics and rehabilitation, Pharmaceutical care, Diabetes mellitus type 2, Treatment, Medical consultation, Glycated hemoglobin, Diabetes, Pharmacy |
| Texto completo: | Texto completo (Ver PDF) |
